Articles related to ANAPHYLAXIS/ALLERGIC REACTIONS

1 Doc, 3 Malpractice Suits—the Most Recent Involving a 2 Year-Old’s Death

The hospital allegedly lacked a pediatric mask and breathing tubes, delaying life-saving care during an anaphylactic emergency.

Emergency Medicine July 3rd 2025

Tags: AIRWAY MANAGEMENT ANAPHYLAXIS/ALLERGIC REACTIONS HOSPITAL OPERATIONS LEGAL MATTERS MALPRACTICE

Medical Professionals Reference (MPR)

Needle-Free Emergency Epinephrine Now Available for Pediatric Patients

Neffy 1mg expands access to emergency epinephrine for children under 30 kg, with a user-friendly nasal spray format and broad affordability programs.

Allergy & Immunology June 5th 2025

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS DEVICE/DRUG APPROVALS FDA

Cleveland Clinic Journal of Medicine (CCJM)

Can My Patient with a ‘Sulfa Allergy’ Receive Celecoxib or Other Nonantimicrobial Sulfonamides?

Nonantimicrobial sulfonamides lack an arylamine group at the N4 position, so they do not cross-react with antimicrobial sulfonamides.

Allergy & Immunology March 31st 2025

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS DRUG SAFETY & INTERACTIONS

MDLinx

Update: Disney Lawsuit Over Doctor’s Fatal Allergic Reaction

Food allergies affect 33 million Americans, with 150 deaths annually from food-related allergic reactions in the US, emphasizing the critical need for stringent allergen management in public dining establishments.

Allergy & Immunology September 3rd 2024

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS FOOD ALLERGIES LEGAL MATTERS

Medical Professionals Reference (MPR)

FDA Approves Neffy, an Epinephrine Nasal Spray for Anaphylaxis

Neffy®, an FDA-approved intranasal epinephrine spray, demonstrates bioequivalence to injectable epinephrine for anaphylaxis treatment in patients weighing ≥30kg, potentially reducing barriers to rapid intervention.

Allergy & Immunology August 16th 2024

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS CRITICAL CARE DEVICE/DRUG APPROVALS FDA

Cleveland Clinic Journal of Medicine (CCJM)

Anaphylaxis: Highlights from the Practice Parameter Update

The updated anaphylaxis guidelines emphasize immediate epinephrine administration at the onset of symptoms and provide comprehensive recommendations for monitoring and follow-up care to prevent recurrence and improve patient education.

Allergy & Immunology May 22nd 2024

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS GUIDELINES/RECOMMENDATIONS PATIENT EDUCATION

1 2 >>

Trending Topics:

Articles related to ANAPHYLAXIS/ALLERGIC REACTIONS

1 Doc, 3 Malpractice Suits—the Most Recent Involving a 2 Year-Old’s Death

Needle-Free Emergency Epinephrine Now Available for Pediatric Patients

Can My Patient with a ‘Sulfa Allergy’ Receive Celecoxib or Other Nonantimicrobial Sulfonamides?

Update: Disney Lawsuit Over Doctor’s Fatal Allergic Reaction

FDA Approves Neffy, an Epinephrine Nasal Spray for Anaphylaxis

Anaphylaxis: Highlights from the Practice Parameter Update

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form